SCDAA Holds 54th Annual Convention

FOR IMMEDIATE RELEASE
14 September 2026

Sickle Cell Disease Association of America to hold 54th annual convention in North Carolina

HANOVER, Md. — The Sickle Cell Disease Association of America Inc. (SCDAA) will hold its 54th Annual National Convention October 15–17, 2026, at the Embassy Suites by Hilton in Concord, North Carolina.

The three-day multidisciplinary convention, themed “HOPE: An Era of Healing, Optimism, Perseverance and Excellence,” will bring together healthcare professionals, researchers, people affected by sickle cell disease, families, community-based organizations, leaders and advocates to discuss advances in treatment, clinical care, research and advocacy.

“We’re bringing together leaders in sickle cell disease research, clinical care, advocacy and community engagement to share knowledge, inspire action and drive progress for individuals and families affected by sickle cell disease,” said Regina Hartfield, president and CEO of SCDAA.

“As we embrace this year’s theme of hope, we look forward to fostering collaboration and empowering attendees with the latest information, resources and strategies to improve lives and take meaningful steps toward a universal cure.”

Featured speakers and sessions

The convention programme will include:

  • Dr. Payal Desai, director of the Sickle Cell Disease Enterprise at Atrium Health Levine Cancer Institute, delivering the Charles F. Whitten, M.D., Memorial Lecture, “Bridging the Gap: Ensuring Lifelong Access to Excellence in Sickle Cell Care.”
  • Dr. Adetola Kassim, professor of medicine in the Division of Hematology and Oncology at Vanderbilt University Medical Center, presenting the Kwaku Ohene-Frempong, M.D., Memorial Symposium, “Stroke Awareness Through the Lifespan.”
  • Dr. Sophie Lanzkron, director of the Division of Hematology at Thomas Jefferson University, delivering the Lennette Benjamin, M.D., Memorial Lecture, “Pain Management Redefined.”
  • Dr. Isaac Odame, director of the Hemoglobinopathy Program at the Hospital for Sick Children, presenting the Global Perspectives on Sickle Cell Disease Lecture, “Perspectives on Sickle Cell Disease in Sub-Saharan Africa.”
  • Dr. Georges C. Benjamin, CEO of the American Public Health Association, presenting “The Current State of Sickle Cell Disease in Today’s Federal Government.”
  • Dr. Adetola Kassim and Dr. Andrew Campbell, director of the Comprehensive Sickle Cell Disease Program at Children’s National, leading the “Summit on Stem Cell Transplant and Cellular Therapies: Where Are We Now?”

Additional activities will include educational workshops, panel discussions, medical reports, exhibit hall presentations, advocacy sessions, awards, social events and an evening gala.

Pfizer is the legacy sponsor of the national convention. Novo Nordisk is the visionary sponsor, and Agios is the diamond sponsor.

To learn more and register, visit the SCDAA Annual National Convention page.

About Sickle Cell Disease Association of America Inc.

The Sickle Cell Disease Association of America Inc. advocates for people affected by sickle cell disease and supports community-based organizations working to improve quality of life, raise public awareness and advance the search for a universal cure. SCDAA and its more than 55 member organizations support sickle cell research, public and professional health education, and patient and community services.

Sickle cell disease is an inherited blood disorder in which red blood cells become sickle-shaped and can block blood flow, causing complications including anemia, stroke, severe pain and organ damage. There is currently no universal cure.

Leave Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

grandpashabet girişgrandpashabet girişdeneme bonusudeneme bonusu veren bahis sitelerideneme bonusu 2026grandpashabet girişGrandpashabetgrandpashabetgrandpashabet deneme bonusugrandpashabet deneme bonusudeneme bonusuGrandpashabetgrandpashabet girişgrandpashabetgrandpashabet güncel girişbahis siteleribahis siteleriGrandpashabet girişjojobetjojobet girişjojobetjojobet girişjojobet girişjojobetjojobet